Advanced search×

Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans.

Hypertension 58(5):935-42 (2011) PMID 21931069 PMCID PMC3209704

Essential hypertension is a proinflammatory, proconstrictor disease coinciding with endothelial dysfunction and inward vessel remodeling. Using the skin circulation, our aim was to determine whether inducible NO synthase (iNOS) upregulation attenuates NO-dependent cutaneous vasodilation in hypertensive humans. We hypothesized that, with hypertension, localized iNOS inhibition would restore vasodilation in response to NO-dependent stimuli, and iNOS expression would be increased and phosphorylated vasodilator-stimulated phosphoprotein would be decreased. For, in vivo protocols, 4 intradermal microdialysis fibers were placed in 9 hypertensive and 10 normotensive men and women (systolic blood pressure: 146±4 versus 113±2 mm Hg; P

Version: za2963e q8zaf q8zb6 q8zc4 q8zd9 q8ze5 q8zf5 q8zg2

Similar articles you may find interesting…

  1. HMGB1 and leukocyte migration during trauma and sterile inflammation

    Mol Immunol 55(1):76-82 (2013) PMID 23207101

    We review recent evidence that the ability of HMGB1 to recruit leukocytes may be entirely due to the formation of a heterocomplex with the homeostatic chemokine CXCL12. The HMGB1-CXCL12 heterocomplex acts on the CXCR4 receptor more potently than CXCL12 alone. Notably, only one of the redox forms of...
  2. Thrombospondin-4 contributes to spinal cord injury-induced changes in nociception.

    Eur J Pain (2013) PMID 23649982

    SCI leads to TSP4 up-regulation in lumbar spinal cord that may play a critical role in mediating centrally mediated behavioural hypersensitivity. Blocking this pathway may be helpful in management of SCI-induced changes in nociception. © 2013 European Federation of International Ass...
  3. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.

    FEBS J (2013) PMID 23647548

    We report that TRAIL suppressed CXCR4-mediated human breast cancer MDA-MB-231 cell migration by up-regulating miR-146a expression through NF-κB. TRAIL receptor 1 (TRAIL-R1, DR4) was highly expressed in TRAIL-treated MDA-MB-231 cells. A neutralization antibody against DR4 specifically blocked TRAIL-...